Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Catheter Precision's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 74.09%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Catheter Precision's 3-Year ROIIC % or its related term are showing as below:
FRA:4RM's 3-Year ROIIC % is ranked better than 86.06% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 1.62
vs FRA:4RM: 74.09
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Catheter Precision 3-Year ROIIC % Related Terms
Catheter Precision 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Catheter Precision's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:4RM vs ALURD, BJDX, AMIX: 3-Year ROIIC % Comparison
For the Medical Devices subindustry, Catheter Precision's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Catheter Precision 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Catheter Precision's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Catheter Precision's 3-Year ROIIC % falls into.
Catheter Precision's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -9.4376016 (Dec. 2025) - -21.513 (Dec. 2022) )
/
( 13.845 (Dec. 2025) - 0.349 (Dec. 2022) )
=
12.0753984
/
13.496
=
89.47%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Catheter Precision (FRA:4RM) has a 3-Year ROIIC % of 74.09 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Catheter Precision and its competitors. According to the industry distribution chart, Catheter Precision ranks #111 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 13.9%.
Is Catheter Precision's 3-Year ROIIC % too high?
Catheter Precision's current 3-Year ROIIC % is 74.09. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.62. Catheter Precision's value of 74.09 is 4473.5% above this industry median. Based on the distribution chart, Catheter Precision ranks #111 out of 796 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Catheter Precision has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Catheter Precision's 3-Year ROIIC % compare to ALURD and BJDX?
According to the Medical Devices & Instruments industry distribution chart, Catheter Precision ranks #111 out of 796 companies for 3-Year ROIIC %. This places Catheter Precision in the top 14% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 1.62. Catheter Precision's value of 74.09 is 4473.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.62, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Catheter Precision's current 3-Year ROIIC % of 74.09 is 4473.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Catheter Precision and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Catheter Precision's current 3-Year ROIIC % is 74.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Catheter Precision stock overvalued right now?
Catheter Precision (FRA:4RM) has a current 3-Year ROIIC % of 74.09. The stock's GF Value™ is €295.71, compared to a current price of €100.89 — trading 65.9% below its estimated fair value. The current 3-Year ROIIC % is 74.09 and 4473.5% above the Medical Devices & Instruments industry median of 1.62. Catheter Precision's overall GF Score™ is 23/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Catheter Precision (FRA:4RM), the current 3-Year ROIIC % is 74.09 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Catheter Precision (FRA:4RM) Overvalued in 2026?
Based on GuruFocus' analysis, Catheter Precision stock appears to be undervalued.
The current stock price of €100.89 is trading 65.9% below its estimated GF Value™ of €295.71.
Key valuation signals for FRA:4RM:
3-Year ROIIC %: 74.09
GF Value™: €295.71 vs. price of €100.89 (65.9% below fair value)
Industry Position: 4473.5% above the Medical Devices & Instruments median (#111 of 796)
No single metric tells the full story. See the FRA:4RM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.
23GF Score
Get the complete analysis for FRA:4RM
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:4RM has been successfully added to your 
